Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis. The ...

The benefits of many elective nonhepatic surgeries outweigh the risks for select patients with compensated cirrhosis, but those at high risk for poor surgical outcomes should continue to seek ...

Although only 7.4% of patients with decompensated cirrhosis included in the study received a palliative care consultation during their initial hospital admission, this intervention was associated with ...

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could nearly double by 2050. By Nina Agrawal Liver cancer kills more than 700,000 ...

Cirrhosis can cause scar tissue to gradually replace healthy liver cells. In time, this can affect liver function and lead to hair, skin, and nail symptoms such as rashes and discoloration. Cirrhosis ...

Cirrhosis is the result of long-term liver injury where healthy tissue is replaced with scar tissue (fibrosis). Common causes of cirrhosis include alcohol use disorder (AUD), nonalcoholic fatty liver ...

MASH significantly contributes to increased deaths and DALYs in the Americas, necessitating targeted public health policies. Despite declining hepatitis B-related liver disease, mortality from alcohol ...

Resmetirom significantly reduced liver stiffness in patients with compensated MASH cirrhosis, with a 6.7 kPa decrease over 2 years. The reduction in liver stiffness may lower the risk of liver-related ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure. The risk of ...